Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Apollo Endosurgery Inc
(NQ:
APEN
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 3, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Apollo Endosurgery Inc
< Previous
1
2
3
Next >
Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021
December 09, 2021
Upgrades According to BMO Capital, the prior rating for Nuvei Corp (NASDAQ:
Via
Benzinga
Apollo Endosurgery to Present at Four Upcoming Investor Conferences
November 12, 2021
AUSTIN, TX / ACCESSWIRE / November 12, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures,...
From
Apollo Endosurgery, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
COVID-19
Legal
Product Safety
Recap: Apollo Endosurgery Q3 Earnings
November 01, 2021
Apollo Endosurgery (NASDAQ:APEN) reported its Q3 earnings results on Monday, November 1, 2021 at 04:00 PM. Here's what investors need to know about the announcement. Earnings...
Via
Benzinga
Apollo Endosurgery, Inc. Reports 28% Revenue Growth in Third Quarter Conference Call and Webcast to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET
November 01, 2021
AUSTIN, TX / ACCESSWIRE / November 1, 2021 / Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today...
From
Apollo Endosurgery, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
COVID-19
Legal
Product Safety
Apollo Endosurgery Announces Publication of a Multicenter Study of Its X-Tack(R)Endoscopic HeliX Tacking System
November 01, 2021
Study demonstrates high success rates, ease of use, and economic value in the treatment of GI defects AUSTIN, TX / ACCESSWIRE / November 1, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a...
From
Apollo Endosurgery, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
COVID-19
Legal
Product Safety
Apollo Endosurgery to Report Third Quarter Financial Results on November 1, 2021
October 27, 2021
AUSTIN, TX / ACCESSWIRE / October 27, 2021 / Apollo Endosurgery, Inc. ("Company" or "Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal...
From
Apollo Endosurgery, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Earnings Scheduled For November 1, 2021
November 01, 2021
Companies Reporting Before The Bell • ANI Pharmaceuticals (NASDAQ:ANIP) is expected to report earnings for its third quarter. • Kiniksa Pharmaceuticals (NASDAQ:...
Via
Benzinga
Apollo Endosurgery Announces Closing of Public Offering and Exercise in Full of Option to Purchase Additional Shares
October 15, 2021
AUSTIN, TX / ACCESSWIRE / October 15, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced...
From
Apollo Endosurgery, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 14, 2021
Gainers NRX Pharmaceuticals (NASDAQ:NRXP) stock increased by 34.63% to $12.71 during Thursday's pre-market session. The company's market cap stands at $683.4...
Via
Benzinga
20 Stocks Moving in Wednesday's Pre-Market Session
October 13, 2021
Gainers Puxin Limited (NYSE: NEW) rose 52.1% to $0.6901 in pre-market trading after dipping 24% on Tuesday. Jasper Therapeutics, Inc. (NASDAQ: JSPR) rose 38% to $9.95 in pre-...
Via
Benzinga
Apollo Endosurgery Announces Pricing of $65 Million Public Offering of Common Stock
October 12, 2021
AUSTIN, TX / ACCESSWIRE / October 12, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced...
From
Apollo Endosurgery, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
COVID-19
Legal
Product Safety
Apollo Endosurgery Announces Commencement of Public Offering of Common Stock
October 12, 2021
AUSTIN, TX / ACCESSWIRE / October 12, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced...
From
Apollo Endosurgery, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
COVID-19
Legal
Product Safety
Apollo Endosurgery Announces Preliminary Third Quarter 2021 Financial Results and Provides Business Updates
October 07, 2021
- Revenue expected between $16.0 million and $16.4 million - Third consecutive quarter of double-digit revenue growth; endoscopic suturing up over 30% - Submitted a De Novo 510(k) Classification...
From
Apollo Endosurgery, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
COVID-19
Legal
Product Safety
Apollo Endosurgery to Present at Lake Street's 5th Annual Best Ideas Growth Conference
September 13, 2021
AUSTIN, TX / ACCESSWIRE / September 13, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today...
From
Apollo Endosurgery, Inc.
Via
AccessWire
Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021
September 09, 2021
Upgrades According to Benchmark, the prior rating for TopBuild Corp (NYSE:
Via
Benzinga
Apollo Endosurgery, Inc. Reports Record Endoscopy Revenue in Second Quarter, Raises Full-Year Outlook Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET
August 03, 2021
AUSTIN, TX / ACCESSWIRE / August 3, 2021 / Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, today...
From
Apollo Endosurgery, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
COVID-19
Legal
Product Safety
Apollo Endosurgery to Report Second Quarter Financial Results on August 3, 2021
July 27, 2021
AUSTIN, TX / ACCESSWIRE / July 27, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric...
From
Apollo Endosurgery, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
COVID-19
Legal
Product Safety
Apollo Endosurgery Appoints Jeffrey G. Black as Chief Financial Officer
July 16, 2021
Veteran Executive Brings 30 Years of Financial and Operational Leadership Experience AUSTIN, TX / ACCESSWIRE / July 16, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in...
From
Apollo Endosurgery, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
COVID-19
Legal
Product Safety
MERIT Study Investigators Announce Successful Achievement of the Study's Primary Efficacy & Safety Endpoints
June 14, 2021
AUSTIN, TX / ACCESSWIRE / June 14, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures,...
From
Apollo Endosurgery, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
COVID-19
Legal
Product Safety
Apollo Endosurgery to Present at June Investor Conferences
June 01, 2021
AUSTIN, TX / ACCESSWWIRE / June 1, 2021 / Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures today...
From
Apollo Endosurgery, Inc.
Via
AccessWire
Apollo Endosurgery's Innovative OverStitch(TM) Endoscopic Suturing System Highlighted During Digestive Disease Week 2021
May 24, 2021
AUSTIN, TX / ACCESSWIRE / May 24, 2021 / Apollo Endosurgery, Inc. ("Apollo") (Nasdaq:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures,...
From
Apollo Endosurgery, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
COVID-19
Legal
Product Safety
Sidoti Microcap Virtual Conference
May 18, 2021
May 19 - 20, 2021 Presentation times and weblinks released for over 60 presenting companies NEW YORK, NY / ACCESSWIRE / May 18, 2021 / Sidoti & Company, LLC has released the presentation schedule and...
From
Sidoti & Company, LLC
Via
AccessWire
Apollo Endosurgery to Present at Sidoti Conference May 20
May 12, 2021
AUSTIN, TX / ACCESSWIRE / May 12, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures today...
From
Apollo Endosurgery, Inc.
Via
AccessWire
Apollo Endosurgery, Inc. Reports 29% Increase in First Quarter Revenue
May 04, 2021
Conference Call to Discuss Results Today at 3:30 p.m. CT / 4:30 p.m. ET AUSTIN, TX / ACCESSWIRE / May 4, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive...
From
Apollo Endosurgery, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
COVID-19
Legal
Product Safety
Apollo Endosurgery Announces Appointments to Commercial Leadership Team
May 03, 2021
Kirk Ellis to Serve as Vice President of US Sales Steve Bosrock to Serve as Vice President of Marketing & Medical Education AUSTIN, TX / ACCESSWIRE / May 3, 2021 / Apollo Endosurgery, Inc. ("Apollo")...
From
Apollo Endosurgery, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
COVID-19
Legal
Product Safety
Apollo Endosurgery to Report First Quarter Financial Results on May 4, 2021
April 28, 2021
AUSTIN, TX / ACCESSWIRE / April 28, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in next-generation minimally invasive medical devices for gastrointestinal and bariatric...
From
Apollo Endosurgery, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
COVID-19
Legal
Product Safety
Apollo Endosurgery Announces Publication of Pre-Clinical Results for X-Tack(TM) Endoscopic HeliX Tacking System
April 21, 2021
Authors conclude, "Compared to TTS clip, X-Tack is superior for effecting large mucosal defect closure, including durable sealing of full-thickness perforation." AUSTIN, TX / ACCESSWIRE / April 21,...
From
Apollo Endosurgery, Inc.
Via
AccessWire
Topics
Regulatory Compliance
Exposures
COVID-19
Legal
Product Safety
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.